Showing results (701-710 of 1,340) with videos related to

Sort By:
Pageof 134
Neuro-Oncology Advances|June 15, 2022
Pleiotropic MLLT10 variation confers risk of meningioma and estrogen-mediated cancersKyle M Walsh, Chenan Zhang, Lisa Calvocoressi, et al.
Neuro-Oncology Advances|May 31, 2021
Timing of glioblastoma surgery and patient outcomes: a multicenter cohort studyDomenique M J Müller, Merijn E De Swart, Hilko Ardon, et al.
Neuro-Oncology Advances|May 27, 2021
Lessons learned from contemporary glioblastoma randomized clinical trials through systematic review and network meta-analysis: part 2 recurrent glioblastomaShervin Taslimi, Vincent C Ye, Patrick Y Wen, et al.
Neuro-Oncology Advances|February 4, 2022
Neutrophil depletion enhanced the Clostridium novyi-NT therapy in mouse and rabbit tumor modelsVerena Staedtke, Tyler Gray-Bethke, Guanshu Liu, et al.
Neuro-Oncology Advances|February 4, 2022
Long-term effectiveness of Gliadel implant for malignant glioma and prognostic factors for survival: 3-year results of a postmarketing surveillance in JapanToshihiko Iuchi, Akihiro Inoue, Yuichi Hirose, et al.
Neuro-Oncology Advances|February 4, 2022
Radiation-induced neuroinflammation: a potential protective role for poly(ADP-ribose) polymerase inhibitors?Rodrigo Gutierrez-Quintana, David J Walker, Kaye J Williams, et al.
Neuro-Oncology Advances|February 4, 2022
A multiparametric pharmacogenomic strategy for drug repositioning predicts therapeutic efficacy for glioblastoma cell linesAshish H Shah, Robert Suter, Pavan Gudoor, et al.
Neuro-Oncology Advances|February 21, 2022
Immune deconvolution and temporal mapping identifies stromal targets and developmental intervals for abrogating murine low-grade optic glioma formationAmanda de Andrade Costa, Jit Chatterjee, Olivia Cobb, et al.
Neuro-Oncology Advances|July 27, 2022
Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumorsKutluay Uluc, Prakash Ambady, Matthew K McIntyre, et al.
Neuro-Oncology Advances|January 31, 2022
Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trialAndrew J Song, Keyue Ding, Iyad Alnahhas, et al.
Pageof 134